CTI BIOPHARMA CORP Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CTI BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CTI BIOPHARMA CORP for March 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 28 2014 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Sell | S | 3.42 | 20,000 | 68,400 | 468,937 | 488.9 K to 468.9 K (-4.09 %) |
Mar 28 2014 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Sell | S | 3.41 | 55,000 | 187,550 | 488,937 | 543.9 K to 488.9 K (-10.11 %) |
Mar 28 2014 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Sell | S | 3.41 | 5,900 | 20,090 | 543,937 | 549.8 K to 543.9 K (-1.07 %) |
Mar 28 2014 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Sell | S | 3.40 | 200 | 681 | 549,837 | 550 K to 549.8 K (-0.04 %) |
Mar 28 2014 | CTIC | CTI BIOPHARMA CORP | GREGORIAN VARTAN | Director | Sell | S | 3.40 | 900 | 3,060 | 550,037 | 550.9 K to 550 K (-0.16 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.59 | 100 | 359 | 448,619 | 448.7 K to 448.6 K (-0.02 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.59 | 1,301 | 4,664 | 448,719 | 450 K to 448.7 K (-0.29 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.58 | 1,599 | 5,724 | 450,020 | 451.6 K to 450 K (-0.35 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.58 | 21,900 | 78,293 | 451,619 | 473.5 K to 451.6 K (-4.62 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.57 | 2,900 | 10,356 | 473,519 | 476.4 K to 473.5 K (-0.61 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.57 | 20,500 | 73,185 | 476,419 | 496.9 K to 476.4 K (-4.13 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.57 | 200 | 714 | 496,919 | 497.1 K to 496.9 K (-0.04 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.57 | 6,900 | 24,599 | 497,119 | 504 K to 497.1 K (-1.37 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.56 | 8,200 | 29,192 | 504,019 | 512.2 K to 504 K (-1.60 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.56 | 6,103 | 21,696 | 512,219 | 518.3 K to 512.2 K (-1.18 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.55 | 13,097 | 46,494 | 518,322 | 531.4 K to 518.3 K (-2.46 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.55 | 2,000 | 7,090 | 531,419 | 533.4 K to 531.4 K (-0.37 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.54 | 8,000 | 28,320 | 533,419 | 541.4 K to 533.4 K (-1.48 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.54 | 4,950 | 17,498 | 541,419 | 546.4 K to 541.4 K (-0.91 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | NUDELMAN PHILLIP M PHD | Director | Sell | S | 3.53 | 2,250 | 7,943 | 546,369 | 548.6 K to 546.4 K (-0.41 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 3.49 | 23,819 | 83,128 | 1,035,234 | 1.1 M to 1 M (-2.25 %) |
Mar 26 2014 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Global Medical ... | Sell | S | 3.46 | 36,181 | 125,186 | 1,059,053 | 1.1 M to 1.1 M (-3.30 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 3.79 | 145,000 | 548,825 | 2,402,794 | 2.5 M to 2.4 M (-5.69 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 3.86 | 250,000 | 965,500 | 2,547,794 | 2.8 M to 2.5 M (-8.94 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 3.82 | 9,906 | 37,841 | 822,897 | 832.8 K to 822.9 K (-1.19 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 3.81 | 23,276 | 88,682 | 832,803 | 856.1 K to 832.8 K (-2.72 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | BIANCO LOUIS A | EVP, Finance & Admi ... | Sell | S | 3.80 | 91,818 | 348,908 | 856,079 | 947.9 K to 856.1 K (-9.69 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.76 | 1,000 | 3,755 | 620,904 | 621.9 K to 620.9 K (-0.16 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.75 | 1,100 | 4,127 | 621,904 | 623 K to 621.9 K (-0.18 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.75 | 300 | 1,125 | 623,004 | 623.3 K to 623 K (-0.05 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.75 | 200 | 750 | 623,304 | 623.5 K to 623.3 K (-0.03 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.75 | 300 | 1,124 | 623,504 | 623.8 K to 623.5 K (-0.05 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.75 | 100 | 375 | 623,804 | 623.9 K to 623.8 K (-0.02 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.75 | 14,000 | 52,430 | 623,904 | 637.9 K to 623.9 K (-2.19 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.74 | 400 | 1,497 | 637,904 | 638.3 K to 637.9 K (-0.06 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.74 | 9,000 | 33,660 | 638,304 | 647.3 K to 638.3 K (-1.39 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.74 | 100 | 374 | 647,304 | 647.4 K to 647.3 K (-0.02 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.74 | 10,800 | 40,338 | 647,404 | 658.2 K to 647.4 K (-1.64 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.73 | 1,400 | 5,225 | 658,204 | 659.6 K to 658.2 K (-0.21 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.73 | 400 | 1,492 | 659,604 | 660 K to 659.6 K (-0.06 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.73 | 18,600 | 69,378 | 660,004 | 678.6 K to 660 K (-2.74 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.73 | 22,086 | 82,270 | 678,604 | 700.7 K to 678.6 K (-3.15 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.72 | 300 | 1,117 | 700,690 | 701 K to 700.7 K (-0.04 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.72 | 2,500 | 9,303 | 700,990 | 703.5 K to 701 K (-0.36 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.72 | 68,656 | 255,400 | 703,490 | 772.1 K to 703.5 K (-8.89 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.72 | 10,158 | 37,737 | 772,146 | 782.3 K to 772.1 K (-1.30 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.71 | 600 | 2,227 | 782,304 | 782.9 K to 782.3 K (-0.08 %) |
Mar 21 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Sell | S | 3.71 | 8,000 | 29,680 | 782,904 | 790.9 K to 782.9 K (-1.01 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.84 | 800 | 3,072 | 509,265 | 510.1 K to 509.3 K (-0.16 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.82 | 1,500 | 5,730 | 510,065 | 511.6 K to 510.1 K (-0.29 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.82 | 600 | 2,290 | 511,565 | 512.2 K to 511.6 K (-0.12 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.81 | 900 | 3,429 | 512,165 | 513.1 K to 512.2 K (-0.18 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.81 | 2,400 | 9,139 | 513,065 | 515.5 K to 513.1 K (-0.47 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.81 | 500 | 1,903 | 515,465 | 516 K to 515.5 K (-0.10 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.80 | 700 | 2,660 | 515,965 | 516.7 K to 516 K (-0.14 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.80 | 200 | 759 | 516,665 | 516.9 K to 516.7 K (-0.04 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.79 | 2,600 | 9,854 | 516,865 | 519.5 K to 516.9 K (-0.50 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.78 | 2,964 | 11,204 | 519,465 | 522.4 K to 519.5 K (-0.57 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.78 | 2,136 | 8,066 | 522,429 | 524.6 K to 522.4 K (-0.41 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.78 | 1,000 | 3,775 | 524,565 | 525.6 K to 524.6 K (-0.19 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.77 | 800 | 3,018 | 525,565 | 526.4 K to 525.6 K (-0.15 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.77 | 2,000 | 7,542 | 526,365 | 528.4 K to 526.4 K (-0.38 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.77 | 5,112 | 19,272 | 528,365 | 533.5 K to 528.4 K (-0.96 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.77 | 1,788 | 6,734 | 533,477 | 535.3 K to 533.5 K (-0.33 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.77 | 700 | 2,636 | 535,265 | 536 K to 535.3 K (-0.13 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.76 | 1,400 | 5,264 | 535,965 | 537.4 K to 536 K (-0.26 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.76 | 400 | 1,502 | 537,365 | 537.8 K to 537.4 K (-0.07 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | LOVE RICHARD L | Director | Sell | S | 3.75 | 11,500 | 43,125 | 537,765 | 549.3 K to 537.8 K (-2.09 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.80 | 300 | 1,139 | 401,170 | 401.5 K to 401.2 K (-0.07 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.79 | 3,600 | 13,644 | 401,470 | 405.1 K to 401.5 K (-0.89 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.79 | 300 | 1,136 | 405,070 | 405.4 K to 405.1 K (-0.07 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.78 | 1,600 | 6,048 | 405,370 | 407 K to 405.4 K (-0.39 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.78 | 3,200 | 12,080 | 406,970 | 410.2 K to 407 K (-0.78 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.77 | 4,897 | 18,462 | 410,170 | 415.1 K to 410.2 K (-1.18 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.77 | 23 | 87 | 415,067 | 415.1 K to 415.1 K (-0.01 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.77 | 2,400 | 9,036 | 415,090 | 417.5 K to 415.1 K (-0.57 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.76 | 5,000 | 18,800 | 417,490 | 422.5 K to 417.5 K (-1.18 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.76 | 600 | 2,253 | 422,490 | 423.1 K to 422.5 K (-0.14 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.75 | 16,815 | 63,056 | 423,090 | 439.9 K to 423.1 K (-3.82 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.75 | 390 | 1,462 | 439,905 | 440.3 K to 439.9 K (-0.09 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.75 | 16,170 | 60,557 | 440,295 | 456.5 K to 440.3 K (-3.54 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.74 | 7,700 | 28,798 | 456,465 | 464.2 K to 456.5 K (-1.66 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.74 | 4,600 | 17,181 | 464,165 | 468.8 K to 464.2 K (-0.98 %) |
Mar 07 2014 | CTIC | CTI BIOPHARMA CORP | Telling Fred | Director | Sell | S | 3.73 | 4,500 | 16,785 | 468,765 | 473.3 K to 468.8 K (-0.95 %) |